1. Home
  2. CVE Database
  3. CVE-2026-21974
MEDIUM · 5.3

CVE-2026-21974

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable...

Vulnerability Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVSS Score

5.3

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
LOW
Integrity
NONE
Availability
NONE

Affected Products

VendorProductVersions
OracleLife Sciences Central Designer7.0.1.0

Related Weaknesses (CWE)

CWE-200

References

FAQ

What is CVE-2026-21974?

CVE-2026-21974 is a vulnerability with a CVSS score of 5.3 (MEDIUM). Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable...

How severe is CVE-2026-21974?

CVE-2026-21974 has been rated MEDIUM with a CVSS base score of 5.3/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-21974?

Check the references section above for vendor advisories and patch information. Affected products include: Oracle Life Sciences Central Designer.